Table 1.
Patient characteristics
| Characteristics | N = 30 | Median (Q1; Q3) |
|---|---|---|
| Male, n (%) | 15 (50) | – |
| Age, (years) | – | 43 (34; 60) |
| Bodyweight, (kg) | – | 73.5 (61; 86) |
| Length, (cm) | – | 173.5 (169; 176) |
| Reason for transplantation, n (%) | ||
| Heart (n = 10) | ||
| Ischemic CMP, n (%) | 5 (17) | – |
| Non-ischemic CMP, n (%) | 5 (17) | – |
| Lung (n = 20) | ||
| Cystic fibrosis, n (%) | 10 (33) | – |
| COPD, n (%) | 3 (10) | – |
| IPAH, n (%) | 2 (7) | – |
| Bronchectasis, n (%) | 1 (3) | – |
| Sarcoidosis, n (%) | 1 (3) | – |
| Langerhans cell histiocytosis, n (%) | 1 (3) | – |
| Idiopathic pulmonary fibrosis, n (%) | 2 (7) | – |
| Double lung transplantation, n (%) | 18 (90) | – |
| Parameters | ||
| Hta | ||
| Day 1 | 0.31 (0.28; 0.35) | |
| Day 2 | 0.28 (0.25; 0.30) | |
| Day 3 | 0.27 (0.25; 0.28) | |
| Day 4 | 0.27 (0.25; 0.29) | |
| Day 5 | 0.27 (0.24; 0.30) | |
| Day 6 | 0.28 (0.27; 0.29) | |
| Albb | ||
| Day 1 | 26.2 (22.5; 29.3) | |
| HDLc | ||
| Day 1 | 0.84 (0.70; 1.06) | |
| AAGd | ||
| Day 1 | 0.89 (0.76; 1.18) | |
| pHe | ||
| Day 1 | 7.39 (7.33; 7.43) | |
| Administration of packed red blood cells, (mL/day) | ||
| Day 1 | 275 (275; 550) | |
| Postoperative ECMO frequency, n (%) | 8 (27) | |
| Postoperative ECMO duration, (days) | 4 (2; 6) | |
AAG α1-acid glycoprotein, Alb albumin, CMP cardiomyopathy, COPD chronic obstructive pulmonary disease, ECMO extracorporeal membrane oxygenator, HDL high-density lipoprotein, Ht hematocrit, IPAH idiopatic pulmonary arterial hypertension, Q quartile
Normal ranges: aHt; male 0.41–0.50, female 0.36–0.46
bAlb: 35–50 g/L
cHDL: male 0.90–1.70, female 1.10–2.00 mmol/L
dAAG: 0.5–1.2 g/L
epH: 7.35–7.45